cryptotanshinone has been researched along with Carcinoma, Squamous Cell in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, XT; Li, CH; Qiu, Y | 1 |
| Fan, HN; Jiang, QK; Liu, YD; Lu, HL; Qian, Y; Wang, Y; Yang, LY; Zhu, XJ | 1 |
2 other study(ies) available for cryptotanshinone and Carcinoma, Squamous Cell
| Article | Year |
|---|---|
Cryptotanshinone inhibits oral squamous cell carcinoma through the autophagic pathway.
Topics: Antineoplastic Agents; Apoptosis; Autophagy; Carcinoma, Squamous Cell; Cell Line, Tumor; Cell Proliferation; Head and Neck Neoplasms; Humans; Mouth Neoplasms; Quality of Life; Squamous Cell Carcinoma of Head and Neck | 2023 |
Cryptotanshinone sensitizes antitumor effect of paclitaxel on tongue squamous cell carcinoma growth by inhibiting the JAK/STAT3 signaling pathway.
Topics: Antineoplastic Agents; Apoptosis; Carcinoma, Squamous Cell; Cell Cycle Checkpoints; Cell Movement; Cell Proliferation; Epithelial-Mesenchymal Transition; Humans; Janus Kinases; Models, Biological; Neoplasm Invasiveness; Paclitaxel; Phenanthrenes; Signal Transduction; STAT3 Transcription Factor; Tongue Neoplasms | 2017 |